Pine Bridge Investments, L.P. Regenxbio Inc. Transaction History

Pine Bridge Investments, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $376,852 - $950,017	-17,528 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$34.54 - $44.87 $373,930 - $485,762	-10,826 Reduced 38.18%	17,528 $718,000
Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $64,348 - $102,828	2,021 Added 7.67%	28,354 $1.01 Million
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $807,324 - $1.14 Million	19,222 Added 270.31%	26,333 $1.35 Million
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $608,177 - $930,442	-14,899 Reduced 67.69%	7,111 $408,000
Q4 2018 Feb 13, 2019	SELL	$39.11 - $75.15 $18,459 - $35,470	-472 Reduced 2.1%	22,010 $924,000
Q3 2018 Nov 13, 2018	SELL	$65.0 - $82.15 $86,775 - $109,670	-1,335 Reduced 5.61%	22,482 $1.7 Million
Q2 2018 Aug 09, 2018	BUY	$27.2 - $74.35 $647,822 - $1.77 Million	23,817 New	23,817 $1.71 Million

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.